Abstract
Non-Hodgkin’s lymphomas of the orbit and ocular adnexa (OOA), the majority of which are extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type (MALT lymphomas), are a rare disorder. The aim of this study was to evaluate the clinical features and treatment outcomes and complications in patients with MALT lymphoma of OOA. Thirty-seven patients with a histologically verified diagnosis of MALT lymphoma of OOA were included in this retrospective, observational case study. There were 22 (59%) men and 15 (41%) women, with a median age of 44 years (range, 21–80 years). The most common presenting complaint was a slowly growing orbital mass. The stages were IAE in 74%, IAEE (bilateral involvement) in 18%, IIIAE in 6%, and IVAE in 3%. None of the patients had an elevated value of LHD or β2-microglobulin. Surgical resection alone was attempted as the sole treatment in two patients, but tumor recurred 19 and 24 months after surgery. Radiotherapy, with a median tumor dose of 3,060 cGy, was administered in 29 patients; all of the patients achieved complete remission, and none of them had severe later complications. Combination chemotherapy alone was employed in three patients with stage IIIAE or IVAE. With a median follow-up duration of 21 months, the 3-year overall survival (OS) rate and event-free survival (EFS) rate were 97% and 86%, respectively. Subgroup analysis of the patients with localized disease, who received radiotherapy as an initial treatment modality, revealed that 3-year OS rate and EFS rate were 100% and 93%, respectively. All disease recurrences were documented histologically as MALT lymphoma. In conclusion complete staging evaluation is needed to select an adequate treatment modality. Radiotherapy alone can produce excellent local control and survival in patients with localized MALT lymphoma of OOA. Systemic chemotherapy should be considered in patients with advanced stages or systemic manifestation.
Similar content being viewed by others
References
Bhatia S, Paulino AC, Buatti JM, Mayr NA, Wen BC (2002) Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 54:818–823
Cho EY, Han JJ, Ree HJ et al (2003) Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 73:87–96
Conconi A, Martinelli G, Thieblemont C et al (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102:2741–2745
Coupland SE, Krause L, Delecluse HJ et al (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 105:1430–1441
Esik O, Ikeda H, Mukai K, Kaneko A (1996) A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin’s lymphomas. Radiother Oncol 38:13–18
Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extra-nodal lymphomas. Cancer 29:252–260
Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI et al (2003) Ocular adnexal lymphoma: clinical behavior or distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 57:1382–1391
Galieni P, Polito E, Leccisotti A et al (1997) Localized orbital lymphoma. Haematologica 82:436–439
Garner A (1992) Orbital lymphoproliferative disorders. Br J Ophthalmol 76:47–48
Harris NL, Jaffe ES, Stein H et al (1994) A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392
Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17:3835–3849
Hasegawa M, Kojima M, Shioya M et al (2003) Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57:172–176
Isaacson PG, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive of B-cell lymphoma. Cancer 52:1410–1416
Isaacson PG, Norton AJ (1994) Mucosa associated lymphoid tissue (MALT) and the MALT lymphoma concept: extranodal lymphomas. Churchill Livingstone, Edinburgh, pp 5–14
Jenkins C, Rose GE, Bunce C et al (2000) Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 84:907–913
Keleit D, Flickinger JC, Hobson SR et al (1992) Radiotherapy of lymphoproliferative disease of the orbit. Am J Clin Oncol 15:422–427
Ko YH, Kim CW, Park CS et al (1998) REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 83:806–812 (Erratum 1999;85:256)
Lee SW, Suh CO, Kim GE et al (2002) Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol 25:261–265
Pelloski CE, Wilder RB, Ha CS et al (2001) Clinical Stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol 59:145–151
Raderer M, Vorbeck F, Formanek M et al (2000) Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 83:454–457
Sasai K, Yamabe H, Dodo Y, Kashii S, Nagata Y, Hiraoka M (2001) Non-Hodgkin’s lymphoma of the ocular adnexa. Acta Oncol 40:485–490
Smitt MC, Donaldson SS (1993) Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys 26:59–66
Thieblemont C, Bastion Y, Berger F et al (1997) Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15:1624–1630
Tsang RW, Gospodarowicz MK, Pintilie M et al (2001) Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 50:1258–1264
Uno T, Isobe K, Shikama N et al (2003) Radiotherapy for extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional retrospective review of 50 patients. Cancer 98:865–871
Wenzel C, Fiebiger W, Dieckmann K, Formanek M, Chott A, Raderer M (2003) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 97:2236–2241
Wotherspoon A, Doglioni C, Isaacson PG (1992) Low-grade gastric B-cell lymphoma of mucosa associated lymphoid tissue (MALT): a multifocal disease. Histopathology 20:29–34
Yahalom J (2001) MALT lymphomas: a radiation oncology viewpoint. Ann Hematol 80[Suppl 3]:B100–B105
Zinzani PL, Magagnoli M, Galieni P et al (1999) Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 17:1254–1258
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, JL., Kim, MK., Lee, K.H. et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue–type of the orbit and ocular adnexa. Ann Hematol 84, 13–18 (2005). https://doi.org/10.1007/s00277-004-0914-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0914-3